Navigation Links
InforMedix Retains Murdock Capital Partners

ROCKVILLE, Md., March 11 /PRNewswire-FirstCall/ -- InforMedix Holdings, Inc. (OTC Bulletin Board: IFMX) is pleased to announce that it has engaged Murdock Capital Partners to provide Capital Markets Advisory Services to InforMedix. Murdock Capital, based in New York City, is a 16 year old firm that specializes in providing professional advice, counsel, and assistance regarding financial matters, including the raising of additional capital, merger and acquisitions, exchange listings, Sarbanes Oxley requirements, investor relations, and any other related issues. Murdock specializes in micro cap entities, and is highly conversant and knowledgeable in the special needs and concerns of smaller capitalization companies, such as InforMedix.

InforMedix CEO, Bruce A. Kehr, M.D., stated, "InforMedix was introduced to Murdock Capital by several of its current large investors and shareholders with whom Murdock has enjoyed solid business relationships for a number of years. Management has been impressed with Murdock's due diligence efforts and the experience, acumen and enthusiasm of the entire Murdock team. As a merchant bank that also has invested in some of its client companies, Murdock brings years of experience in assisting in the development of strategic business relationships. InforMedix is embarking on a rapid ramp of our basic businesses, and management believes that it is important for the company to gain significant additional exposure to the investment community at this exciting inflection point. Murdock's proven record of introducing companies to highly sophisticated, micro cap oriented investors was highly evident in our discussions and negotiations with Murdock's management team. We believe that their ability to attract the attention of long term investors interested in our story will be of significant benefit to our current shareholder base."

Dr. Kehr went on to state, "To discuss InforMedix with Murdock Capital, they would be pleased to entertain your call. By simply identifying yourself as interested in InforMedix, you will be directed to the proper party. Murdock's phone number is 212 421-2545, or you can reach them by e mail at"

About InforMedix

InforMedix, Inc., based in Rockville, Maryland, has developed the Med- eMonitor(TM) System as The Medication Adherence Solution for consumer product and disease management markets, to deliver peace-of-mind, improved independent living, and better health outcomes to patients and their loved ones. The Med- eMonitor System ("Medication, Safe and Easy"(TM)) integrates a portable patient-interactive "smart pillbox", hardware, software, and 24/7 monitoring. This is designed to enable chronically ill patients and their loved ones, professionals in disease management programs, and medical researchers to efficiently monitor and manage Med-eMonitor users' medication and care plan adherence, clinical response, and drug safety. For more information, visit

About Murdock Capital Partners

Murdock Capital Partners, based in New York City, is a private merchant banking firm providing corporate finance and financial advisory services. Murdock Capital acts as financial intermediary and principal for small and medium size companies and provides business counsel on a company's finances, including mergers and acquisitions, public and private financing, management buy-outs and corporate divestitures. Murdock Capital's professionals create significant value for their client companies by acting in a multi faceted capacity as financial partners and strategic advisers. Preferable transactions are $3 million to $50 million; however situations that require up to $200 million for later stage companies are well within Murdock's purview. Acting as principals and working with a substantial number of institutions, fund managers, venture capital firms and high net worth individuals, Murdock Capital arranges investments in small and medium size companies, to provide expansion and acquisition financing to facilitate the growth strategies of successful managers. For the past fifteen years, Murdock has remained committed to its objective of identifying, investing in and funding well managed companies that demonstrate the potential for substantial long-term growth. Our knowledge and experience in formulating corporate strategy including marketing, strategic alliances and business management greatly increases the probability of our clients' success. For bridge, mezzanine, or other capital requirements, Murdock Capital accesses a variety of sources of capital and has successfully raised funds for a number of firms on specially structured terms, including PIPES, Private Placements, Secondary Offerings, Initial Public Offerings, management buyouts and private equity financings. Murdock Capital has developed a national and international network of investment and private banks, money managers, institutional investors, non- bank lenders and leveraged buy out groups.

Safe Harbor Statement

This press release may contain forward looking statements that involve risks and uncertainties, including statements regarding our business strategy and development plans, plans for entering into new businesses, anticipated sources and uses of funds and other statements regarding our plans, objectives, expectations and intentions that are not historical facts. Because these forward-looking statements involve risks and uncertainties, actual results could differ materially from those discussed in this press release. These risks and uncertainties are described in greater detail in the reports that we file with the Securities and Exchange Commission. Our actual results, performance or achievements may vary materially from those expressed or implied in any forward-looking statements. All forward-looking statements reflect our beliefs and expectations as of the date of this press release and should not be relied upon as representing our views as of any subsequent date. While we may elect to update these forward-looking statements publicly at some point in the future, we specifically disclaim any obligation to do so, whether as a result of new information, future events or otherwise.

SOURCE InforMedix Holdings, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Autism Consultant Valerie Herskowitz Retains NewsMark Public Relations to Herald the Autism Support Village and Launch of
2. Renhuang Pharmaceuticals, Inc. Retains CCG Elite
3. SpectraScience, Inc. Retains Hayden Communications
4. Leading Cosmetic Dermatologist, Peter G. Ballas II MD, Retains Kay Renz Public Relations to Promote his Practice and New Skincare Line
5. Diagnostic Centers of America Retains NewsMark Public Relations to Showcase Its Rise as Only Medical Facility in South Florida With Worlds Most Advanced Cardiac Scanner
6. Big A Drug Stores, Inc. Retains DJM Realty to Dispose of All Stores Operating Under the Names of Drug Emporium, Big A, Camelot, Drug Fair and Drug Barn
7. QMed, Inc. Retains Lazard Middle Market
8. The Ultimate Stress Reliever, SpaCapsule(R), the Capsule that Takes You on a Rejuvenating Journey to the Spa, Retains TransMedia Group for Soothing PR
9. Genesis Technology Group Retains CCG Elite
10. MaxLife Fund Corp. retains the Law firm, Anslow & Jaclin, LLP of Manalapan, N.J., to review MaxLife Fund Corp. options to be listed on the NASDAQ Capital Market
11. Bioponic Phytoceuticals Retains OTC Financial Network for Investor Relations
Post Your Comments:
(Date:12/1/2015)... ... December 01, 2015 , ... Baptist Medical Center Jacksonville ... is the only hospital in the region providing what is known as the ... pacing patients were revealed recently at a medical conference and published in The ...
(Date:12/1/2015)... ... December 01, 2015 , ... December 1, 2015 ... of the company’s growing product line of food safety and seafood fraud prevention ... (Oncorhynchus nerka) – allow InstantLabs to offer fast, reliable species identification for the ...
(Date:12/1/2015)... ... December 01, 2015 , ... Diabetic foot wounds ... Podiatrists are well aware that psychology-based patient non-compliance (disobedience of a health care ... to diseases of the diabetic foot. The American Board of Multiple Specialties ...
(Date:12/1/2015)... ... 01, 2015 , ... SAN FRANCISCO, Calif. (December 1, 2015) ... has awarded Education and Developmental Therapies (EDT), an Applied Behavior Analysis (ABA) service ... special needs providers that excel in synthesizing the areas of clinical quality, staff ...
(Date:12/1/2015)... ... December 01, 2015 , ... PYA’s latest white paper, “ ... a main “pain point” for merging or aligning healthcare provider organizations—when mergers and ... signed. This quick-read guidance suggests that failing to recognize the power of ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... 2015 ... of the "2016 Europe Enteric ... Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, ... offering. --> ) ... "2016 Europe Enteric Disease Testing ...
(Date:12/1/2015)... , Dec. 1, 2015 CytRx Corporation (NASDAQ: ... specializing in oncology, today announced that it has reached ... pivotal global Phase 3 clinical trial of aldoxorubicin in ... originally estimated to be completed in Q1 2016. The Phase ... under a Special Protocol Assessment from the FDA at ...
(Date:12/1/2015)... Dec. 1, 2015   Craneware, Inc ., ... solutions, today announced the company will showcase a ... ® solution at the American Society ... Meeting . The new features are focused on ... monitoring and managing enterprise-wide pharmacy charges to ensure ...
Breaking Medicine Technology: